In contrast, treatment with ligands of TLR-2 or TLR-5 did not affect viral capture (Fig 4E, lanes 2–3) but led to an increased productive infection of IL-4 DCs (Fig 4F, lanes 2–3). Here, TLR5 is linked to infection.